Judge Rules For Cytomedix In Patent Suit Over Platelet Releasates

Law360, New York (March 26, 2004, 12:00 AM EST) -- A federal judge has ruled that the claims of a patent at the center of a lawsuit filed by biotech company Cytomedix against a foot clinic should be broadly construed, according to the plaintiff.

U.S. District Court Judge James B. Zagel of the Northern District of Illinois ruled that the patent should be construed to cover any treating composition that contains all of the materials released by platelets during the platelet release reaction.

Defendant Little Rock Foot Clinic had disputed the scope of the claims in...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.